The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical experience of intravenous temozolomide therapy for gliomas.
K. Motomura
No relevant relationships to disclose
A. Natsume
No relevant relationships to disclose
M. Fujii
No relevant relationships to disclose
H. Momota
No relevant relationships to disclose
T. Wakabayashi
No relevant relationships to disclose